Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Pertento Partners LLP and Eduardo Marques filed an amended Schedule 13G reporting passive ownership in Nutex Health, Inc. common stock. As of 12/31/2025, they beneficially owned 324,422 shares, representing 4.6% of the outstanding common stock, with shared voting and dispositive power.
All reported shares are directly owned by advisory clients of Pertento Partners, and no individual client is described as holding more than 5% of the class. The filers state the holdings were not acquired to change or influence control of Nutex Health.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Nutex Health (NUTX) does Pertento Partners report?
Pertento Partners LLP and Eduardo Marques report beneficial ownership of 324,422 Nutex Health shares, representing 4.6% of the company’s common stock as of December 31, 2025. They hold shared voting and dispositive power over all of these shares.
What type of filing did Pertento Partners make for Nutex Health (NUTX)?
Pertento Partners LLP and Eduardo Marques filed an Amendment No. 1 to Schedule 13G for Nutex Health common stock. A Schedule 13G is a passive ownership report for holders exceeding certain thresholds, indicating no intent to influence control.
Who are the reporting persons in the Nutex Health (NUTX) Schedule 13G/A?
The reporting persons are Pertento Partners LLP and Eduardo Marques. Pertento is organized in the United Kingdom, while Marques is a Brazilian citizen and Managing Partner of Pertento. Both report identical beneficial ownership and shared voting and dispositive power figures.
How are the Nutex Health (NUTX) shares held by Pertento Partners’ clients?
All 324,422 Nutex Health shares reported are directly owned by advisory clients of Pertento Partners LLP. The filing states that none of these advisory clients may be deemed to beneficially own more than 5% of the Nutex Health common stock class.
Does Pertento Partners seek control of Nutex Health (NUTX) with this stake?
The filing certifies the Nutex Health securities were not acquired and are not held for changing or influencing control of the issuer. It also notes they are not held in connection with any transaction intended to affect control, other than limited nomination-related activities.
What ownership powers do Pertento Partners and Eduardo Marques have over Nutex Health (NUTX) shares?
Pertento Partners LLP and Eduardo Marques report zero sole voting or dispositive power over Nutex Health shares. Instead, they report shared voting and shared dispositive power over 324,422 shares, reflecting how the holdings are managed for advisory clients.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Nutex Health, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
67079U306
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
67079U306
1
Names of Reporting Persons
Pertento Partners LLP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED KINGDOM
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
324,422.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
324,422.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
324,422.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.6 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP No.
67079U306
1
Names of Reporting Persons
Eduardo Marques
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
BRAZIL
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
324,422.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
324,422.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
324,422.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.6 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Nutex Health, Inc.
(b)
Address of issuer's principal executive offices:
6030 S. Rice Ave, Suite C, Houston, Texas 77081
Item 2.
(a)
Name of person filing:
Pertento Partners LLP
Eduardo Marques
(b)
Address or principal business office or, if none, residence:
Pertento Partners LLP
111 Park Street
London W1K7JL
United Kingdom
Eduardo Marques
111 Park Street
London W1K7JL
United Kingdom
(c)
Citizenship:
Pertento Partners LLP - United Kingdom
Eduardo Marques - Brazil
(d)
Title of class of securities:
Common Stock, $0.001 par value
(e)
CUSIP No.:
67079U306
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G amendment are directly owned by advisory clients of Pertento Partners LLP. None of those advisory clients may be deemed to beneficially own more than 5% of the Common Stock, $0.01 par value.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Pertento Partners LLP
Signature:
/s/ Eduardo Marques
Name/Title:
Eduardo Marques, Managing Partner
Date:
02/11/2026
Eduardo Marques
Signature:
/s/ Eduardo Marques
Name/Title:
Eduardo Marques
Date:
02/11/2026
Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
